Front. Oncol. Frontiers in Oncology Front. Oncol. 2234-943X Frontiers Media S.A. 10.3389/fonc.2026.1796339 Correction Correction: Beyond surface dose: subcutaneous dose escalation underlies TomoTherapy’s skin toxicity in breast radiotherapy XueJiao 1 ZhaoWenjun 2 WuChenchen 1 * Writing – original draft Writing – review & editing Department of Radiation Oncology, The First Affiliated Hospital of Soochow University, Suzhou, China State Key Laboratory of Radiation Medicine and Protection, School for Radiological and Interdisciplinary Sciences (RAD-X), Collaborative Innovation Center of Radiation Medicine of Jiangsu Higher Education Institutions, Soochow University, Suzhou, China Correspondence: Chenchen Wu, wcc2119@suda.edu.cn 11 02 2026 2026 16 1796339 26 01 2026 28 01 2026 Copyright © 2026 Xue, Zhao and Wu. 2026 Xue, Zhao and Wu https://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. A Correction on Beyond surface dose: subcutaneous dose escalation underlies TomoTherapy’s skin toxicity in breast radiotherapy By Xue J, Zhao W and Wu C (2026) Front. Oncol. 16:1760716. doi: 10.3389/fonc.2026.1760716 acute skin toxicity breast cancer radiotherapy setup helical tomotherapy (TOMO) P-PAST volumetric modulated arc therapy (VMAT) section-at-acceptance Breast Cancer

There was a mistake in the captions of Figures 1 and 3 as published. The captions for Figures 1 and 3 were erroneously swapped. The corrected captions of Figures 1 and 3 appear below.

Figures 1

“Comparison of dosimetric parameters between Synergy and TOMO groups.”

Figures 3

“Comparison of dosimetric parameters within the PTV-projected adjacent superficial tissue (P-PAST) between Synergy and TOMO groups.”

The original version of this article has been updated.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Edited and reviewed by: Atsuto Katano, The University of Tokyo Hospital, Japan